Article

Determinants of Targeted Cancer Therapy Use in Community Oncology Practice: A Qualitative Study using the Theoretical Domains Framework and Rummler-Brache Process Mapping

2022-03-16

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>Precision medicine holds enormous potential to improve outcomes for cancer patients, offering improved rates of cancer control and quality of life. Not all patients who could benefit from targeted cancer therapy receive it, and some who may not benefit do receive targeted therapy. We sought to comprehensively identify determinants of targeted therapy use among com...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1b7bb0ca-9667-5139-84e9-2770823439fb
DOI: 10.21203/rs.3.rs-1439561/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Determinants of Targeted Cancer Therapy Use in Community Oncology Practice: A Qualitative Study using the Theoretical Domains Framework and Rummler-Brache Process MappingDOI 10.21203/rs.3.rs-1439561/v1Read

Clinical utility of a regional precision medicine molecular tumor board and challenges to implementation.Semantic proximity Read

Accessing Targeted Therapies: A Potential Roadblock to Implementing Precision Oncology?Semantic proximity Read

Incongruence Between Prerequisite Molecular Testing and Treatment with Personalized Therapies for Non-Small Cell Lung Cancer: A Surveillance, Epidemiology and End Results-Medicare Study.Semantic proximity Read

Organ-specialty–led implementation of comprehensive genomic profiling in gynecological oncology: a nationwide survey in JapanSemantic proximity Read

Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative studySemantic proximity Read

Application of a Concise Video to Improve Patient Understanding of Tumor Genomic Testing in Community and Academic Practice SettingsSemantic proximity Read

Implementation Mapping for Managing Patients at High Risk for Hereditary Cancer.Semantic proximity Read

Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI)Semantic proximity Read

Informed Consent in Genomic Testing: Healthcare Professionals’ Perceptions on the Value of a Dynamic Consent Platform in Precision OncologySemantic proximity Read

Socioeconomic and Clinical Determinants Driving Access to BRCA Genetic Testing in Cancer : A Case-Control Study Using Observational Electronic Health Records Across Multiple SitesSemantic proximity Read

Improving biomarker testing in advanced non-small-cell lung cancer and metastatic colorectal cancer: experience from a large community oncology network in the USA.Semantic proximity Read

Factors Influencing Cancer Genetic Somatic Mutation Test Ordering By Cancer PhysiciansSemantic proximity Read